Jagsonpal Pharmaceuticals Limited (BOM: 507789)

Market Cap	17.22B
Revenue (ttm)	2.27B
Net Income (ttm)	243.00M
Shares Out	n/a
EPS (ttm)	9.04
PE Ratio	70.86
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Sep 6, 2024

Volume	36,303
Open	652.45
Previous Close	640.50
Day's Range	588.95 - 663.25
52-Week Range	270.05 - 820.05
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 6, 2025

About Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. It serves health care professionals and government institutions. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, I...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1978
• Employees: 1,025
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 507789

Financial Performance

In 2023, Jagsonpal Pharmaceuticals's revenue was 2.09 billion, a decrease of -11.83% compared to the previous year's 2.37 billion. Earnings were 224.63 million, a decrease of -15.94%.